232 related articles for article (PubMed ID: 7690736)
41. Primary gastric CD30 (Ki-1)-positive large cell non-Hodgkin's lymphomas. A clinicopathologic analysis of six cases.
Paulli M; Rosso R; Kindl S; Boveri E; Bonoldi E; Stracca V; Motta T; Arrigoni G; Lazzarino M; Menestrina F
Cancer; 1994 Feb; 73(3):541-9. PubMed ID: 8299075
[TBL] [Abstract][Full Text] [Related]
42. Comparison of anaplastic large cell Ki-1 lymphomas and microvillous lymphomas in their immunologic and ultrastructural features.
Kinney MC; Glick AD; Stein H; Collins RD
Am J Surg Pathol; 1990 Nov; 14(11):1047-60. PubMed ID: 2173429
[TBL] [Abstract][Full Text] [Related]
43. Aberrant expression of macrophage-associated antigens (CD68 and Ki-M1P) by Schwann cells in reactive and neoplastic neural tissue. Light- and electron-microscopic findings.
Kaiserling E; Xiao JC; Ruck P; Horny HP
Mod Pathol; 1993 Jul; 6(4):463-8. PubMed ID: 8415593
[TBL] [Abstract][Full Text] [Related]
44. Diagnostic significance of histiocyte-related markers in malignant histiocytosis and true histiocytic lymphoma.
Nemes Z; Thomázy V
Cancer; 1988 Nov; 62(9):1970-80. PubMed ID: 2901905
[TBL] [Abstract][Full Text] [Related]
45. Fine needle aspiration cytology, histology and immunohistochemistry of anaplastic large cell Ki-1-positive lymphoma. A report of three cases.
McCluggage WG; Anderson N; Herron B; Caughley L
Acta Cytol; 1996; 40(4):779-85. PubMed ID: 8693905
[TBL] [Abstract][Full Text] [Related]
46. Anaplastic large cell malignant lymphoma with extensive eosinophilic or neutrophilic infiltration.
McCluggage WG; Walsh MY; Bharucha H
Histopathology; 1998 Feb; 32(2):110-5. PubMed ID: 9543666
[TBL] [Abstract][Full Text] [Related]
47. Immunophenotypic profile of myeloid cells in granulocytic sarcoma by immunohistochemistry. Correlation with blast differentiation in bone marrow.
Chang CC; Eshoa C; Kampalath B; Shidham VB; Perkins S
Am J Clin Pathol; 2000 Nov; 114(5):807-11. PubMed ID: 11068557
[TBL] [Abstract][Full Text] [Related]
48. CD68 reactivity of non-macrophage derived tumours in cytological specimens.
Doussis IA; Gatter KC; Mason DY
J Clin Pathol; 1993 Apr; 46(4):334-6. PubMed ID: 7684403
[TBL] [Abstract][Full Text] [Related]
49. My4 antibody staining of non-Hodgkin's lymphomas.
Medeiros LJ; Herrington RD; Gonzalez CL; Jaffe ES; Cossman J
Am J Clin Pathol; 1991 Mar; 95(3):363-8. PubMed ID: 1705092
[TBL] [Abstract][Full Text] [Related]
50. B-cell lineage confers a favorable outcome among children and adolescents with large-cell lymphoma: a Pediatric Oncology Group study.
Hutchison RE; Berard CW; Shuster JJ; Link MP; Pick TE; Murphy SB
J Clin Oncol; 1995 Aug; 13(8):2023-32. PubMed ID: 7636544
[TBL] [Abstract][Full Text] [Related]
51. Fine-needle aspiration biopsy of Ki-1-positive anaplastic large-cell lymphoma.
Akhtar M; Ali MA; Haider A; Antonius J; Hainau B; al Dayel F
Diagn Cytopathol; 1992; 8(3):242-7. PubMed ID: 1318825
[TBL] [Abstract][Full Text] [Related]
52. Morphologic, immunphenotypic and clinical discriminators between T-cell/histiocyte-rich large B-cell lymphoma and lymphocyte-predominant Hodgkin lymphoma.
Mourad WA; Al Thani S; Tbakhi A; Al Omari M; Khafaga Y; Shoukri M; El Weshi A; Al Shabana M; Ezzat A
Hematol Oncol Stem Cell Ther; 2008; 1(1):22-7. PubMed ID: 20063524
[TBL] [Abstract][Full Text] [Related]
53. Antibody BNH9 detects red blood cell-related antigens on anaplastic large cell (CD30+) lymphomas.
Delsol G; Blancher A; al Saati T; Ralfkiaer E; Lauritzen A; Bruigères L; Brousset P; Rigal-Huguet F; Mazerolles C; Robert A
Br J Cancer; 1991 Aug; 64(2):321-6. PubMed ID: 1716454
[TBL] [Abstract][Full Text] [Related]
54. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study.
Leoncini L; Del Vecchio MT; Kraft R; Megha T; Barbini P; Cevenini G; Poggi S; Pileri S; Tosi P; Cottier H
Am J Pathol; 1990 Nov; 137(5):1047-57. PubMed ID: 2173409
[TBL] [Abstract][Full Text] [Related]
55. Malignant histiocytosis. A reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies.
Wilson MS; Weiss LM; Gatter KC; Mason DY; Dorfman RF; Warnke RA
Cancer; 1990 Aug; 66(3):530-6. PubMed ID: 2194647
[TBL] [Abstract][Full Text] [Related]
56. Immunologic markers in non-Hodgkin's lymphoma.
Freedman AS; Nadler LM
Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
[TBL] [Abstract][Full Text] [Related]
57. [Morphological and immunohistochemical analysis of Ki-1 lymphoma].
Kobayashi T; Nagasawa T; Abe T; Mori N
Rinsho Ketsueki; 1992 Sep; 33(9):1183-90. PubMed ID: 1331563
[TBL] [Abstract][Full Text] [Related]
58. Immunohistochemical characterization of mast cell disease in paraffin sections using tryptase, CD68, myeloperoxidase, lysozyme, and CD20 antibodies.
Li WV; Kapadia SB; Sonmez-Alpan E; Swerdlow SH
Mod Pathol; 1996 Oct; 9(10):982-8. PubMed ID: 8902835
[TBL] [Abstract][Full Text] [Related]
59. Ki-1-positive anaplastic large cell lymphoma with different phenotypes in skin nodules and lymph nodes.
Oka K; Matsumoto T
Dermatology; 1994; 188(1):52-6. PubMed ID: 8305759
[TBL] [Abstract][Full Text] [Related]
60. Cytomorphology and immunocytochemistry of fine needle aspirates from blastic non-Hodgkin's lymphomas.
Tani E; Liliemark J; Svedmyr E; Mellstedt H; Biberfeld P; Skoog L
Acta Cytol; 1989; 33(3):363-71. PubMed ID: 2728790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
